IBYME   02675
INSTITUTO DE BIOLOGIA Y MEDICINA EXPERIMENTAL
Unidad Ejecutora - UE
artículos
Título:
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells
Autor/es:
MERCEDES BEATRIZ FUERTES; AALOK K. KACHA; JUSTIN KLINE; SENG-RYONG WOO; DAVID M. KRANZ; KENNETH M. MURPHY; THOMAS F. GAJEWSKI
Revista:
JOURNAL OF EXPERIMENTAL MEDICINE
Editorial:
ROCKEFELLER UNIV PRESS
Referencias:
Año: 2011 vol. 208 p. 2005 - 2016
ISSN:
0022-1007
Resumen:
Despite lack of tumor control in many models, spontaneous T cell priming occurs frequently in response to a growing tumor. However, the innate immune mechanisms that promote natural antitumor T cell responses are undefined. In human metastatic melanoma, there was a correlation between a type I interferon (IFN) transcriptional profile and T cell markers in metastatic tumor tissue. In mice, IFN-b was produced by CD11c(+) cells after tumor implantation, and tumor-induced T cell priming was defective in mice lacking IFN-a/bR or Stat1. IFN signaling was required in the hematopoietic compartment at the level of host antigen-presenting cells, and selectively for intratumoral accumulation of CD8a(+) dendritic cells, which were demonstrated to be essential using Batf3(-/-) mice. Thus, host type I IFNs are critical for the innate immune recognition of a growing tumor through signaling on CD8a(+) DCs